INTRODUCTION {#sec1-1}
============

Tumor hypoxia has been shown to drive malignant progression,\[[@ref1]\] induce genetic instability,\[[@ref2]\] and gene amplification,\[[@ref3]\] as well as impair DNA repair mechanisms.\[[@ref4]\] In particular, in prostate cancer, hypoxia was identified *in vivo*\[[@ref5]\] and showed a significant association with advanced tumor stage\[[@ref6]\] and aggressive disease.\[[@ref7]\] Other studies showed an increased resistance to androgen deprivation and radio- and chemotherapy\[[@ref8][@ref9][@ref10]\] of tumors with large hypoxic regions. To create optical oxygen supply maps, we used a human *ex vivo* model, based on the compound pimonidazole.\[[@ref11]\] Pimonidazole (hypoxyprobe™ -1; Chemicon International, Inc., Billerica, MA, USA), a 2-nitroimidazole, accumulates *in vivo* in hypoxic tissue (pO~2~ ≤ 10 mmHg at 37°C) and can be easily visualized in surgical specimens (ex vivo) by immunohistochemical analysis.\[[@ref12]\] Pimonidazole is generally used in animal models, pimonidazole-based hypoxia labeling in human tissue samples is rarely performed because of ethical, pharmacological, and legal restrictions. To overcome these limitations, correlations between pimonidazole labeling and superimpositions with other known hypoxia-related proteins, including osteopontin (OPN),\[[@ref13][@ref14]\] hypoxia-inducible factor 1-alpha (HIF1A),\[[@ref15][@ref16]\] and glucose transporter member 1 (GLUT1),\[[@ref17][@ref18]\] were investigated. Here, we describe a new method to reliably detect hypoxic tumor regions that does not employ invasive techniques, to further investigate hypoxia and hypoxia-related markers in prostatectomy specimens.

PROCEDURE {#sec1-2}
=========

To verify that pimonidazole serves as a robust marker for hypoxia in prostate cancer cells, we incubated LNCaP cells (American Type Culture Collection, Manassas, VA, USA) under normoxic and hypoxic conditions, with or without pimonidazole. In accordance with the findings of previous studies,\[[@ref11][@ref12]\] we confirmed pimonidazole as a direct marker for hypoxia. Immunocytochemical staining of pimonidazole revealed a clear positivity in LNCaP cells under hypoxic conditions while cells cultured under normoxic conditions were negative for pimonidazole \[[Figure 1a](#F1){ref-type="fig"}\].

![(a) *In vitro* validation of the anti-pimonidazole antibody by immunocytochemical staining using LNCaP prostate cancer cells. (b) Immunohistochemical staining for pimonidazole, osteopontin (O), hypoxia-inducible factor 1-alpha (H), and glucose transporter member 1 (G), scale bars 2 mm and 100 μm. (c) Generation of oxygen supply maps. (d) Dot-wise comparisons of both oxygen supply maps (OHG vs. P) in one representative case. (e and f) Box plots with Spearman correlation coefficients and mutual information comparing pimonidazole with osteopontin (O), hypoxia-inducible factor 1-alpha (H), glucose transporter member 1 (G), and combinatory overlays for 15 patients](JPI-7-3-g001){#F1}

After *in vivo* administration of pimonidazole, following radical prostatectomy, a total of 15 prostatectomy specimens \[for cohort information see Supplementary Table 1\] were subjected to immunohistochemical staining for pimonidazole, OPN, GLUT1, and HIF1A \[[Figure 1b](#F1){ref-type="fig"}\]. Pimonidazole, GLUT1, and OPN showed a medium to strong cytoplasmic overall staining intensity, particularly of cancer tissues. Qualitative analysis of pimonidazole staining showed partial spatial overlapping of all hypoxia markers. A study in advanced head and neck squamous cell carcinoma described the rationale for colocalization of different hypoxia-related proteins with pimonidazole:\[[@ref19]\] Individual hypoxia markers were higher expressed in pimonidazole-positive areas. However, the overall single correlation was poor. To this end, we targeted this issue by pooling all available information from hypoxia-related proteins to construct oxygen supply maps.

###### 

Clinico-pathological data

###### 

Click here for additional data file.

The staining images for the known hypoxia-related proteins OPN (O), GLUT1 (G), and HIF1A (H) of each case were automatically color corrected, aligned, superimposed, and normalized for the generation of a pseudo-colored oxygen supply map \[[Figure 1c](#F1){ref-type="fig"}, OHG\]. First, the original images were white-balanced to remove the grayish background. Second, the tissue regions were automatically identified and rotated, translated, cropped, and rescaled for rough alignment of the tissues to the middle slice. The background was then deleted to remove background artifacts which could disturb the following alignment process. Third, for pixel-wise matching and to conform to morphological changes of the tissues in consecutive slices, we incorporated a nonlinear SIFT flow algorithm\[[@ref20]\] (see online methods for detailed description of all steps). Furthermore, an analogous oxygen supply map based on pimonidazole staining was created \[[Figure 1c](#F1){ref-type="fig"}, pimonidazole\]. These maps were then normalized by histogram equalization and compared for each case using a dot-wise correlation of both images, which yielded high Spearman correlation coefficients \[[Figure 1e](#F1){ref-type="fig"} and Supplementary Figure 1a-o\] and mutual information (MI) \[[Figure 1f](#F1){ref-type="fig"}\]. MI between two images *X* and *Y* has been calculated as ![](JPI-7-3-g002.jpg) where *P(x)* is the probability of intensity *x* in the normalized histogram of *X* and *P(x, y)* is the probability of *x* and *y* in the normalized joint histogram of *X* and *Y*. All image processing steps were implemented in MATLAB 2014a, automatically performed and visually approved. A most simple combinatorial information of O, H, and G overlay maps were generated as the mean of individual intensity maps (more sophisticated combinations have not been considered in this study). Pimonidazole compared with an overlay of all three hypoxia markers (OHG) was highly correlative \[Spearman correlation coefficient, *r* = 0.93, MI = 2.45; [Figure 1d](#F1){ref-type="fig"}\]. Comparison of pimonidazole with single markers (O, H, G) and combinatory overlays (OH, OG, HG) also showed high correlation coefficients \[[Figure 1e](#F1){ref-type="fig"}\]. Only two cases revealed lower correlation coefficients \[Supplementary Table 2\]; B12-4671, B12-6064\] because of crush artifacts. MI increases significantly in overlay images when combined with two or three markers \[[Figure 1f](#F1){ref-type="fig"}\]. As previously shown,\[[@ref11]\] scant correlations with microvessel density and pimonidazole could be observed in representative overlays of pimonidazole with CD34 immunoreactivity (*n* = 2, data not shown).
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(a-o) Spearman correlation matrices of O, H, G and combinations thereof. Oxygen supply maps based on pimonidazole staining and overlay images (OHG) for each of the 15 prostatectomy specimens are provided
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Click here for additional data file.
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Spearman correlation coefficients with pimonidazole
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Click here for additional data file.

CONCLUSION {#sec1-3}
==========

Here, we introduce a computer-assisted approach to detect oxygen gradients in human prostate cancer tissues by colocalization of the expression of validated hypoxia-related markers compared to intravenously administered pimonidazole. The generated oxygen supply maps can be used to precisely colocalize potential hypoxia-related proteins in a quantitative and pictorial manner and will render compounds, such as pimonidazole, unnecessary in human patients.
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